Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
1
NEA
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Borea therapeuticsBorea Therapeutics: Next-generation viral vectors for targeted gene therapy.
ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system…
GeneVentiv TherapeuticsVenture round $1.4M · 4 yr ago · Founded 2020 · 11-50 employees
GeneVentiv Therapeutics — advancing gene therapy approaches.
Alia therapeuticsSeed $4.8M · 3 yr ago · 11-50 employees
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…

Overview

Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
NEAVia a fund
673 portfolio companies

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hatfield United States
HQ
50-200 est. staff
2801 Sterling Drive, Hatfield, PA, 19440-1956, US
company site